9 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
A Systems medicine approach to chronic inflammatory disease (SYSCID)
Date du début: 1 janv. 2017, Date de fin: 31 mars 2022,
"The SYSCID consortium aims to develop a systems medicine approach for disease prediction in CID. We will focus on three major CID indications with distinct characteristics, yet a large overlap of their molecular risk map: inflammatory bowel disease, systemic lupus erythematodes and rheumatoid arthritis. We have joined 15 partners from major cohorts and initiatives in Europe (e.g.IHEC, ICGC, Twins ...
Voir le projet
16
Participants partenaires
TERMINÉ
Exploitation of Glycosylation Signatures for Precision Medicine (GlySign)
Date du début: 1 oct. 2016, Date de fin: 30 sept. 2020,
GlySign is a research training network for the translation of glycomic clinical biomarkers for Precision Medicine (PM). Complex, distinctive changes occur in the glycomics profiles or - Glycan Signatures - of human glycoproteins during progression of many chronic diseases including cancer and inflammatory conditions. The three beneficiaries of the GlySign Consortium have been instrumental in contr ...
Voir le projet
3
Participants partenaires
TERMINÉ
Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeutics (GlyCoCan)
Date du début: 1 sept. 2015, Date de fin: 31 août 2019,
Colorectal cancer (CRC) is a major worldwide cancer burden with about 1.4 million cases in 2012 and an annual mortality of approximately 700,000. Early detection is crucial as treatment is most efficient in early stages where population based screenings could substantially reduce incidence and mortality.Current screening techniques are invasive or lack sensitivity and specificity. Moreover, the mo ...
Voir le projet
9
Participants partenaires
TERMINÉ
Multi-dimensional omics approach to stratification of patients with low back pain (PAIN-OMICS)
Date du début: 1 sept. 2013, Date de fin: 31 août 2018,
"Pain-OMICS is a multidisciplinary consortium of leading clinical, academic and SME researchers in pain and different omics technologies. Genome-wide association studies identified a number of loci associated with pain, but the level of knowledge about underlying mechanisms of different pain syndromes as well as individual variation in the disease course remains inadequate. Pain-OMICS will capital ...
Voir le projet
11
Participants partenaires
TERMINÉ
Methods for high-throughput glycoproteomic analysis (HTP-GlycoMet)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,
... fractionation of complex biological fluids (BIA-SEP), (ii) purification of proteins from body fluids and membrane proteins (UNI-RI), (iii) high-throughput glycomic analysis by use of chromatography (Genos) and multiplexed capillary gel electrophoresis (MPI) and (iv) expertise in the field of viral immunology (MEDRI) we can achieve significant progress in this direction. All our partners are recog ...
Voir le projet
6
Participants partenaires
TERMINÉ
Methods for Integrated analysis of Multiple Omics datasets (MIMOmics)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2017,
MIMOmics develops statistical methods for the integrated analysis of metabolomics, proteomics, glycomics and genomic datasets in large studies. Our project is based on our involvement in studies participating in EU funded projects, i.e. GEHA, IDEAL, Mark-Age, ENGAGE and EuroSpan. In these consortia the primary goal is to identify molecular profiles that monitor and explain complex traits with nove ...
Voir le projet
15
Participants partenaires
TERMINÉ
Methods for high-throughput (HTP) analysis of protein glycosylation (HighGlycan)
Date du début: 1 nov. 2011, Date de fin: 31 oct. 2016,
Glycosylation is a post-translational modification that enriches protein complexity and function. Dysregulation of glycosylation is associated with a wide range of diseases, including cancer, diabetes, as well as congenital, cardiovascular, immunological and infectious disorders. A number of studies identified potentially important glycan disease biomarkers. With regard to biotechnology, proper gl ...
Voir le projet
9
Participants partenaires
TERMINÉ
Diagnostic and prognostic biomarkers for inflammatory bowel disease IBD-BIOM (IBD-BIOM)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2016,
Inflammatory bowel diseases affect 0.8% of the Europeans, and are associated with high morbidity, definite mortality and an increasing economic burden. Current diagnostic tools and therapeutics for IBD are unsatisfactory. Development of biomarkers allowing insights into pathogenesis, prognosis and targeted therapy is a major unmet need. This programme addresses that need. IBD-BIOM is a multidisci ...
Voir le projet
11
Participants partenaires
TERMINÉ
Tools for the Detection of Novel Glyco-biomarkers (GlycoBioM)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2015,
Glycosylation patterns on glycoproteins and glycolipids are involved in the regulation of inter- and intracellular recognition events and alteration of such glycosylation has been observed in many diseases, notably in a variety of cancers. We propose that a systematic, large scale investigation in this area will provide a rich spectrum of novel and structurally diverse carbohydrate-based highly sp ...
Voir le projet